Nicotinamide: Clinical Trials

22 trials of Nicotinamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 5 unknown, 4 recruiting, 1 active not recruiting. 22 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 222Completed 10, Unknown 5, Recruiting 4, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 33Active not recruiting 1, Completed 1, Unknown 1
Phase 12Completed 2

Follow Nicotinamide: new trials by email Literature Review of Nicotinamide trials Research Report on Nicotinamide

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)
Nicotinamide, Standard Glaucoma Therapy - Glaucoma, Open-angle, Primary Open Angle Glaucoma (POAG)
Phase 2Not yet recruitingUniversity of Chicago962027-06-012026-10-13
Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals
Maraviroc, Dolutegravir, Dendritic Cell Vaccine - Hiv, HIV I Infection
Phase 2RecruitingFederal University of São Paulo702026-07-152026-08-19
Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients
Nicotinamide Riboside, Nicotinamide, Nicotinamide Mononucleotide - Glaucoma
Phase 2RecruitingChristopher Kai Shun Leung1382025-05-192025-06-26
Nicotinamide Supplementation Improves Physical Performance in Older Adults at Risk of Falls
Nicotinamide, Placebo - Frailty, Fall
Phase 2UnknownUniversity of Chile602024-05-212024-06-20
Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Nicotinamide, Placebo - Fatty Liver, Obesity
Phase 2RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau302024-04-232025-11-18
Tolerance and Efficacy Nicotinamide (Vitamin B3) in Dominant Optic Atrophy OPA1
Nicotinamide - Nicotinamide Adverse Reaction
Phase 2 / Phase 3Active not recruitingUniversity Hospital, Angers252024-01-232026-04-01
Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia
Nicotinamide, Placebo - Friedreich Ataxia
Phase 2WithdrawnRWTH Aachen University2023-04-012024-01-24
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
Nicotinamide, Placebo - Chronic Lymphocytic Leukemia, Non-melanoma Skin Cancer (NMSC)
Phase 2RecruitingUniversity of Utah862022-02-252026-11-12
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Psilocybin, Nicotinamide - Treatment-resistant Depression
Phase 2CompletedCentral Institute of Mental Health, Mannheim1442021-06-102025-01-20
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Niacinamide Oral Tablet, Antidiabetic - Non Alcoholic Fatty Liver Disease
Phase 2CompletedAin Shams University612019-01-152020-01-22
Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial
Nicotinamide, Placebo oral capsule - Non-melanoma Skin Cancer, Carcinoma, Squamous Cell
Phase 2UnknownWomen's College Hospital1202018-12-032023-04-06
Study of Nicotinamide in Early Onset Preeclampsia
nicotinamide - Pre-Eclampsia, Pregnancy Related
Phase 2CompletedUniversity of North Carolina, Chapel Hill232017-11-012022-09-08
Early Life Interventions for Childhood Growth and Development In Tanzania
Azithromycin Oral Liquid Product, Nitazoxanide Oral Suspension, Nicotinamide - Malnutrition, Stunting
Phase 2 / Phase 3CompletedHaydom Lutheran Hospital11882017-09-052021-05-10
Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus
nicotinamide - Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus Rash
Phase 2UnknownSecond Xiangya Hospital of Central South University402017-08-312021-02-02
Nicotinamide as an Early Alzheimer's Disease Treatment
Nicotinamide, Placebo Comparator - Alzheimer's Disease, Mild Cognitive Impairment
Phase 2CompletedUniversity of California, Irvine462017-07-122023-10-17
Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Niacinamide, Placebo - Polycystic Kidney Disease
Phase 2CompletedUniversity of Kansas Medical Center362015-09-222019-02-11
The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
Nicotinamide, Lanthanum Carbonate, Placebo (for Nicotinamide) - Chronic Kidney Disease
Phase 2CompletedThe Cleveland Clinic2052015-03-012021-08-02
Anticancer Activity of Nicotinamide on Lung Cancer
Nicotinamide - Non-Small-Cell Lung Carcinoma
Phase 2 / Phase 3UnknownIl Yeong Park, Ph.D.1102015-03-012020-01-27
Effect of Nicotinamide in Friedreich's Ataxia
nicotinamide - Neurodegenerative Disorders
Phase 2UnknownImperial College London402012-06-012017-07-02
Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
Nicotinamide - Chronic Kidney Disease, Hemodialysis
Phase 2CompletedMedice Arzneimittel Pütter GmbH & Co KG2522010-08-012012-01-18

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Alzheimer Disease (2)  ·  Dementia (2)  ·  Neurodegenerative Diseases (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Renal Insufficiency, Chronic (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Anxiety Disorders (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Fatty Liver (1)

Sponsors

University of California, Irvine (2)  ·  Ain Shams University (1)  ·  Central Institute of Mental Health, Mannheim (1)  ·  Christopher Kai Shun Leung (1)  ·  Federal University of São Paulo (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Haydom Lutheran Hospital (1)  ·  Il Yeong Park, Ph.D. (1)  ·  Imperial College London (1)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)  ·  Medice Arzneimittel Pütter GmbH & Co KG (1)  ·  RWTH Aachen University (1)  ·  Second Xiangya Hospital of Central South University (1)  ·  The Cleveland Clinic (1)  ·  University Hospital, Angers (1)

Countries

United States (8)  ·  Germany (3)  ·  France (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Egypt (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  South Korea (1)  ·  Tanzania (1)

Top investigators

Alan Yu, M.B., B.Chir (1)  ·  An-Wen Chan, MD DPhil (1)  ·  Charles S. Grob, MD (1)  ·  Estomih Mduma (1)  ·  Felipe H Salech Morales, MD-PhD (1)  ·  Il Yeong Park, PhD (1)  ·  Jennifer J Gassman, Ph.D. (1)  ·  John W. Kusek, PhD (1)  ·  Joseph Kim, MD PhD (1)  ·  Joshua Grill, Ph.D. (1)  ·  Kim Boggess, MD (1)  ·  Linda F Fried, MD (1)  ·  Lindsey Fitzgerald, MD (1)

Results publications

PMID 20819978, PMID 24794816, PMID 29982218, PMID 31085679, PMID 32345747, PMID 33324899, PMID 34582462, PMID 35222903, PMID 36963502, PMID 38570905, PMID 38593249, PMID 39032770, PMID 39356039, PMID 39671543, PMID 40069789, PMID 40576086, PMID 41232946, PMID 41848690, PMID 42309304

NIH funding

2009 (1), 2023 (1), R03HD092370 (1), R21DK104086 (1), U01DK099877 (1)